Avid Bioservices Inc (CDMO)

[Bungler]

I believe it is very positive, especially when considering the statements made by some on this board that the Co. would never again mention the 2nd-line NSCLC trial, and instead move on to "other things" to divert attention and hope the 2nd-line trial would be forgotten. That is clearly not the case; they are still focused on the 2nd-line NSCLC trial and it is not going to be "forgotten."